Eligible candidates are invited for Walk-in-Interview for filling up of the following contractual posts in the project entitled “A Phase II Open Label Randomized Clinical Trial to Evaluate the Anti Bacterial Activity, Safety, Tolerability and Pharmacokinetics of a Combination of PA-824, Moxifloxacin and Pyrazinamide, or PA-824 When Administered with the Category IV Regimen of RNTCP in Adult Males with Newly Diagnosed Multi-drug Resistant Pulmonary Tuberculosis” as per details given below:
Post: Junior Research Fellow (Clinical)



ABOUT AUTHORS
National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an 'Institute of National Importance'. It is an autonomous body set up under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India. The Institute is conceived to provide leadership in pharmaceutical sciences and related areas not only within the country, but also to the countries in South East Asia, South Asia and Africa. NIPER is a member of Association of Indian Universities and Association of Commonwealth Universities.
